CU20210071A7 - Proceso para la preparación de una imidazoquinolina sustituida - Google Patents
Proceso para la preparación de una imidazoquinolina sustituidaInfo
- Publication number
- CU20210071A7 CU20210071A7 CU2021000071A CU20210071A CU20210071A7 CU 20210071 A7 CU20210071 A7 CU 20210071A7 CU 2021000071 A CU2021000071 A CU 2021000071A CU 20210071 A CU20210071 A CU 20210071A CU 20210071 A7 CU20210071 A7 CU 20210071A7
- Authority
- CU
- Cuba
- Prior art keywords
- preparation
- substituted imidazoquinoline
- quinolin
- imidazo
- pyran
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- SQQXRXKYTKFFSM-UHFFFAOYSA-N chembl1992147 Chemical class OC1=C(OC)C(OC)=CC=C1C1=C(C)C(C(O)=O)=NC(C=2N=C3C4=NC(C)(C)N=C4C(OC)=C(O)C3=CC=2)=C1N SQQXRXKYTKFFSM-UHFFFAOYSA-N 0.000 title 1
- 229940124669 imidazoquinoline Drugs 0.000 title 1
- MOTWRGZBKMOCKM-UHFFFAOYSA-N N-[4-[4-amino-2-(2-methoxyethyl)imidazo[4,5-c]quinolin-1-yl]butyl]-N-(oxan-4-yl)acetamide Chemical compound NC1=NC=2C=CC=CC=2C2=C1N=C(N2CCCCN(C(C)=O)C1CCOCC1)CCOC MOTWRGZBKMOCKM-UHFFFAOYSA-N 0.000 abstract 2
- RHKWIGHJGOEUSM-UHFFFAOYSA-N 3h-imidazo[4,5-h]quinoline Chemical class C1=CN=C2C(N=CN3)=C3C=CC2=C1 RHKWIGHJGOEUSM-UHFFFAOYSA-N 0.000 abstract 1
- 102000004127 Cytokines Human genes 0.000 abstract 1
- 108090000695 Cytokines Proteins 0.000 abstract 1
- 229940123384 Toll-like receptor (TLR) agonist Drugs 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000006698 induction Effects 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 230000002194 synthesizing effect Effects 0.000 abstract 1
- 239000003970 toll like receptor agonist Substances 0.000 abstract 1
- 229940044616 toll-like receptor 7 agonist Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/46—Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
<p>La presente invención se refiere a un proceso para sintetizar N-(4-(4-amino-2-(2-metoxietil)-1H-imidazo[4,5-c]quinolin-1-il)butil)-N-(tetrahidro-2H-piran-4-il)acetamida, un derivado de imidazoquinolina útil como agonista de receptor tipo toll, en particular como agonista de TLR7, que promueve la inducción de ciertas citocinas. Además, la presente invención también proporciona intermedios útiles en la síntesis de N-(4-(4-amino-2-(2-metoxietil)-1H-imidazo[4,5-c]quinolin-1-il)butil)-N-(tetrahidro-2H-piran-4-il)acetamida</p>
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP2019055793 | 2019-03-07 | ||
| PCT/EP2020/056047 WO2020178434A1 (en) | 2019-03-07 | 2020-03-06 | Process for the preparation of a substituted imidazoquinoline |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CU20210071A7 true CU20210071A7 (es) | 2022-04-07 |
| CU24679B1 CU24679B1 (es) | 2023-09-07 |
Family
ID=69723965
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU2021000071A CU24679B1 (es) | 2019-03-07 | 2020-03-06 | Proceso para la preparación de una imidazoquinolina sustituida |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20220144822A1 (es) |
| EP (1) | EP3935047B1 (es) |
| JP (1) | JP7576038B2 (es) |
| KR (1) | KR20210136033A (es) |
| CN (1) | CN113518775B (es) |
| AU (1) | AU2020231822A1 (es) |
| BR (1) | BR112021016960A2 (es) |
| CL (1) | CL2021002322A1 (es) |
| CO (1) | CO2021011258A2 (es) |
| CU (1) | CU24679B1 (es) |
| DK (1) | DK3935047T3 (es) |
| ES (1) | ES2992926T3 (es) |
| IL (1) | IL286054A (es) |
| MX (1) | MX2021010669A (es) |
| PH (1) | PH12021552106A1 (es) |
| SG (1) | SG11202108752YA (es) |
| WO (1) | WO2020178434A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023083439A1 (en) * | 2021-11-09 | 2023-05-19 | BioNTech SE | Tlr7 agonist and combinations for cancer treatment |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6756382B2 (en) | 1999-06-10 | 2004-06-29 | 3M Innovative Properties Company | Amide substituted imidazoquinolines |
| US6573273B1 (en) | 1999-06-10 | 2003-06-03 | 3M Innovative Properties Company | Urea substituted imidazoquinolines |
| US6451810B1 (en) * | 1999-06-10 | 2002-09-17 | 3M Innovative Properties Company | Amide substituted imidazoquinolines |
| US6677349B1 (en) | 2001-12-21 | 2004-01-13 | 3M Innovative Properties Company | Sulfonamide and sulfamide substituted imidazoquinolines |
| PE20040945A1 (es) * | 2003-02-05 | 2004-12-14 | Warner Lambert Co | Preparacion de quinazolinas substituidas |
| US8778963B2 (en) | 2003-11-25 | 2014-07-15 | 3M Innovative Properties Company | Hydroxylamine and oxime substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines |
| DK2155743T3 (da) * | 2007-05-08 | 2012-11-05 | Astrazeneca Ab | Imidazoquinoliner med immunmodulerende egenskaber |
| SI2276486T1 (sl) * | 2008-03-24 | 2014-01-31 | 4Sc Discovery Gmbh | Novi substituirani imidazokinolini |
| WO2011068233A1 (en) * | 2009-12-03 | 2011-06-09 | Dainippon Sumitomo Pharma Co., Ltd. | Imidazoquinolines which act via toll - like receptors (tlr) |
| US8735386B2 (en) * | 2010-07-23 | 2014-05-27 | Boehringer Ingelheim International Gmbh | Aminopyrazoloquinazolines |
| UA113280C2 (xx) * | 2010-11-11 | 2017-01-10 | АМІНОСПИРТЗАМІЩЕНІ ПОХІДНІ 2,3-ДИГІДРОІМІДАЗО$1,2-c]ХІНАЗОЛІНУ, ПРИДАТНІ ДЛЯ ЛІКУВАННЯ ГІПЕРПРОЛІФЕРАТИВНИХ ПОРУШЕНЬ І ЗАХВОРЮВАНЬ, ПОВ'ЯЗАНИХ З АНГІОГЕНЕЗОМ | |
| CN108794467A (zh) * | 2017-04-27 | 2018-11-13 | 博笛生物科技有限公司 | 2-氨基-喹啉衍生物 |
| BR112020004505A2 (pt) * | 2017-09-06 | 2020-09-15 | BioNTech SE | imidazoquinolinas substituídas como agonistas de tlr7 |
| WO2019048036A1 (en) * | 2017-09-06 | 2019-03-14 | Biontech Ag | SUBSTITUTED IMIDAZOQUINOLINES |
-
2020
- 2020-03-06 CU CU2021000071A patent/CU24679B1/es unknown
- 2020-03-06 MX MX2021010669A patent/MX2021010669A/es unknown
- 2020-03-06 KR KR1020217029506A patent/KR20210136033A/ko not_active Ceased
- 2020-03-06 ES ES20707669T patent/ES2992926T3/es active Active
- 2020-03-06 AU AU2020231822A patent/AU2020231822A1/en not_active Abandoned
- 2020-03-06 EP EP20707669.6A patent/EP3935047B1/en active Active
- 2020-03-06 US US17/432,017 patent/US20220144822A1/en not_active Abandoned
- 2020-03-06 DK DK20707669.6T patent/DK3935047T3/da active
- 2020-03-06 CN CN202080018804.8A patent/CN113518775B/zh not_active Expired - Fee Related
- 2020-03-06 PH PH1/2021/552106A patent/PH12021552106A1/en unknown
- 2020-03-06 SG SG11202108752YA patent/SG11202108752YA/en unknown
- 2020-03-06 BR BR112021016960A patent/BR112021016960A2/pt not_active Application Discontinuation
- 2020-03-06 JP JP2021552887A patent/JP7576038B2/ja active Active
- 2020-03-06 WO PCT/EP2020/056047 patent/WO2020178434A1/en not_active Ceased
-
2021
- 2021-08-26 CO CONC2021/0011258A patent/CO2021011258A2/es unknown
- 2021-09-01 IL IL286054A patent/IL286054A/en unknown
- 2021-09-06 CL CL2021002322A patent/CL2021002322A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN113518775A (zh) | 2021-10-19 |
| MX2021010669A (es) | 2021-09-28 |
| KR20210136033A (ko) | 2021-11-16 |
| EP3935047B1 (en) | 2024-08-07 |
| IL286054A (en) | 2021-10-31 |
| CL2021002322A1 (es) | 2022-05-13 |
| AU2020231822A1 (en) | 2021-08-26 |
| CN113518775B (zh) | 2024-10-29 |
| CA3132229A1 (en) | 2020-09-10 |
| WO2020178434A1 (en) | 2020-09-10 |
| SG11202108752YA (en) | 2021-09-29 |
| DK3935047T3 (da) | 2024-09-09 |
| JP2022525023A (ja) | 2022-05-11 |
| US20220144822A1 (en) | 2022-05-12 |
| ES2992926T3 (en) | 2024-12-19 |
| PH12021552106A1 (en) | 2022-05-30 |
| CO2021011258A2 (es) | 2021-09-09 |
| EP3935047A1 (en) | 2022-01-12 |
| BR112021016960A2 (pt) | 2021-11-23 |
| CU24679B1 (es) | 2023-09-07 |
| JP7576038B2 (ja) | 2024-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1125021T1 (el) | Κιναζολινες ως αναστολεις διαυλων ιοντων καλιου | |
| CR20150371A (es) | Inhibidores de prmt5 y sus usos | |
| UY32640A (es) | Aril-pirimidinas como inhibidoras de sintasa dfe aldosterona | |
| EA201101297A1 (ru) | Аддитивные соли аминов, содержащих гидроксильные и/или карбоксильные группы, с производными аминоникотиновой кислоты в качестве ингибиторов dhodh | |
| GEP20227397B (en) | Inhibitors of influenza viruses replication | |
| DOP2012000004A (es) | Inhibidores de bace | |
| MX2010001837A (es) | Derivados de 4-pirimidinasulfamida. | |
| CL2017002354A1 (es) | Compuestos derivados de heteroarilos bicíclicos fusionados con actividad como inhibidores de phd. | |
| CY1122731T1 (el) | Διαμορφωτες υποδοχεα οιστρογονων | |
| CY1115577T1 (el) | Μεθοδος για την παρασκευη εναντιομερικως καθαρων αμινων | |
| CU20120021A7 (es) | Derivados amido espirocíclicos | |
| GT200600117A (es) | Nuevos compuestos farmaceuticos | |
| CO6751286A2 (es) | Síntesis de derivados de 2-carboxamida-cicloamino-urea | |
| PH12015500795B1 (en) | N-(2-(cyclic amine)ethyl)benzamide derivatives as p2x7 inhibitors | |
| CL2021002322A1 (es) | Proceso para la preparación de una imidazoquinolina sustituida | |
| EA200700365A1 (ru) | Производные индол-2-карбоксамидина как антагонисты nmda рецептора | |
| ECSP088360A (es) | Métodos para preparar derivados de ácido glutámico | |
| CY1115983T1 (el) | Συνθεση toy aliskiren | |
| IN2012DN01661A (es) | ||
| PA8848001A1 (es) | Pirrolidinas | |
| MX2022007916A (es) | Conjugados que experimentan rearreglos intramoleculares. | |
| ECSP099554A (es) | Nuevo procedimiento de obtención de la forma cristalina v de la agomelatina | |
| IL206611A0 (en) | Novel imidazolinylmethyl aryl sulfonamides | |
| CY1116687T1 (el) | Παραγωγα πυραζολιου χρησιμα ως αναστολεις της συνθασης της αλδοστερονης | |
| MX2013004881A (es) | Proceso para la preparacion de n-(bencil)ciclopropanaminas sustituidas mediante hidrogenacion de iminas. |